Abstract
While tumor metastases represent the primary driver of cancer-related mortality, our understanding of the mechanisms that underlie metastatic initiation and progression remains incomplete. Recent work identified a novel tumor-macrophage hybrid cell population, generated through the fusion between neoplastic and immune cells. These hybrid cells are detected in primary tumor tissue, peripheral blood, and in metastatic sites. In-depth analyses of hybrid cell biology indicate that they can exploit phenotypic properties of both parental tumor and immune cells, in order to intravasate into circulation, evade the immune response, and seed tumors at distant sites. Thus, it has become increasingly evident that the development and dissemination of tumor-immune hybrid cells play an intricate and fundamental role in the metastatic cascade and can provide invaluable information regarding tumor characteristics and patient prognostication. In this chapter, we review the current understanding of this novel hybrid cell population, the specific hallmarks of cancer that these cells exploit to promote cancer progression and metastasis, and discuss exciting new frontiers that remain to be explored.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CHCs:
-
Circulating hybrid cells
- CTCs:
-
Circulating tumor cells
- EMT:
-
Epithelial to mesenchymal transition
- EpCAM:
-
Epithelial cellular adhesion molecule
- FISH:
-
Fluorescence in situ hybridization
- GFP:
-
Green fluorescent protein
- GVHD:
-
Graft versus host disease
- MET:
-
Mesenchymal to epithelial transition
- MMP:
-
Matrix metalloproteinase
- PBMCs:
-
Peripheral blood mononuclear cells
- RFP:
-
Red fluorescent protein
- TAMs:
-
Tumor-associated macrophages
- VEGF:
-
Vascular endothelial growth factor
References
Aichel O (1911) Über Zellverschmelzung mit qualitativ abnormer Chromosomenverteilung als Ursache der Geschwulstbildung, vol 13. W. Engelmann, Leipzig
Allan AL, Vantyghem SA, Tuck AB, Chambers AF, Chin-Yee IH, Keeney M (2005) Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry. Cytometry A 65(1):4–14. https://doi.org/10.1002/cyto.a.20132
Avilès D, Jami J, Rousset JP, Ritz E (1977) Tumor x host cell hybrids in the mouse: chromosomes from the normal cell parent maintained in malignant hybrid tumors. J Natl Cancer Inst 58(5):1391–1399. https://doi.org/10.1093/jnci/58.5.1391
Ben-David U, Amon A (2020) Context is everything: aneuploidy in cancer. Nat Rev Genet 21(1):44–62. https://doi.org/10.1038/s41576-019-0171-x
Boveri T (2008) Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci 121 Suppl 1:1–84. https://doi.org/10.1242/jcs.025742
Cancer Statistics Center (2020) American Cancer Society. http://cancerstatisticscenter.cancer.org. Accessed 1 Dec 2022
Cao MF, Chen L, Dang WQ, Zhang XC, Zhang X, Shi Y, Yao XH, Li Q, Zhu J, Lin Y, Liu S, Chen Q, Cui YH, Zhang X, Bian XW (2019) Hybrids by tumor-associated macrophages × glioblastoma cells entail nuclear reprogramming and glioblastoma invasion. Cancer Lett 442:445–452. https://doi.org/10.1016/j.canlet.2018.11.016
Casanova-Acebes M, Dalla E, Leader AM, LeBerichel J, Nikolic J, Morales BM, Brown M, Chang C, Troncoso L, Chen ST, Sastre-Perona A, Park MD, Tabachnikova A, Dhainaut M, Hamon P, Maier B, Sawai CM, Agulló-Pascual E, Schober M, Brown BD, Reizis B, Marron T, Kenigsberg E, Moussion C, Benaroch P, Aguirre-Ghiso JA, Merad M (2021) Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. Nature 595(7868):578–584. https://doi.org/10.1038/s41586-021-03651-8
Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, Bolognia JL, Pawelek JM (2000) A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res 60(9):2512–2519
Chakraborty A, Lazova R, Davies S, Bäckvall H, Ponten F, Brash D, Pawelek J (2004) Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant 34(2):183–186. https://doi.org/10.1038/sj.bmt.1704547
Clawson GA, Kimchi E, Patrick SD, Xin P, Harouaka R, Zheng S, Berg A, Schell T, Staveley-O’Carroll KF, Neves RI, Mosca PJ, Thiboutot D (2012) Circulating tumor cells in melanoma patients. PLoS One 7(7):e41052. https://doi.org/10.1371/journal.pone.0041052
Clawson GA, Matters GL, Xin P, Imamura-Kawasawa Y, Du Z, Thiboutot DM, Helm KF, Neves RI, Abraham T (2015) Macrophage-tumor cell fusions from peripheral blood of melanoma patients. PLoS One 10(8):e0134320. https://doi.org/10.1371/journal.pone.0134320
Davies PS, Powell AE, Swain JR, Wong MH (2009) Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS One 4(8):e6530. https://doi.org/10.1371/journal.pone.0006530
DeNardo DG, Andreu P, Coussens LM (2010) Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev 29(2):309–316. https://doi.org/10.1007/s10555-010-9223-6
de Visser KE, Coussens LM (2006) The inflammatory tumor microenvironment and its impact on cancer development. Contrib Microbiol 13:118–137. https://doi.org/10.1159/000092969
de Wit S, Zeune LL, Hiltermann TJN, Groen HJM, Dalum GV, Terstappen L (2018) Classification of cells in CTC-enriched samples by advanced image analysis. Cancers (Basel) 10(10). https://doi.org/10.3390/cancers10100377
Dietz MS, Sutton TL, Walker BS, Gast CE, Zarour L, Sengupta SK, Swain JR, Eng J, Parappilly M, Limbach K, Sattler A, Burlingame E, Chin Y, Gower A, Mira JLM, Sapre A, Chiu YJ, Clayburgh DR, Pommier SJ, Cetnar JP, Fischer JM, Jaboin JJ, Pommier RF, Sheppard BC, Tsikitis VL, Skalet AH, Mayo SC, Lopez CD, Gray JW, Mills GB, Mitri Z, Chang YH, Chin K, Wong MH (2021) Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors. Sci Rep 11(1):13630. https://doi.org/10.1038/s41598-021-93053-7
Ding J, Jin W, Chen C, Shao Z, Wu J (2012) Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS One 7(7):e41942. https://doi.org/10.1371/journal.pone.0041942
Duelli D, Lazebnik Y (2003) Cell fusion: a hidden enemy? Cancer Cell 3(5):445–448. https://doi.org/10.1016/s1535-6108(03)00114-4
Durmus NG, Tekin HC, Guven S, Sridhar K, Arslan Yildiz A, Calibasi G, Ghiran I, Davis RW, Steinmetz LM, Demirci U (2015) Magnetic levitation of single cells. Proc Natl Acad Sci U S A 112(28):E3661–E3668. https://doi.org/10.1073/pnas.1509250112
Fortuna MB, Dewey MJ, Furmanski P (1989) Cell fusion in tumor development and progression: occurrence of cell fusion in primary methylcholanthrene-induced tumorigenesis. Int J Cancer 44(4):731–737. https://doi.org/10.1002/ijc.2910440430
Fortuna MB, Dewey MJ, Furmanski P (1990) Enhanced lung colonization and tumorigenicity of fused cells isolated from primary MCA tumors. Cancer Lett 55(2):109–114. https://doi.org/10.1016/0304-3835(90)90019-t
Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3(5):362–374. https://doi.org/10.1038/nrc1075
Gast CE, Silk AD, Zarour L, Riegler L, Burkhart JG, Gustafson KT, Parappilly MS, Roh-Johnson M, Goodman JR, Olson B, Schmidt M, Swain JR, Davies PS, Shasthri V, Iizuka S, Flynn P, Watson S, Korkola J, Courtneidge SA, Fischer JM, Jaboin J, Billingsley KG, Lopez CD, Burchard J, Gray J, Coussens LM, Sheppard BC, Wong MH (2018) Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv 4(9):eaat7828. https://doi.org/10.1126/sciadv.aat7828
Goldenberg DM (1968) [On the progression of malignity: a hypothesis]. Klin Wochenschr 46(16):898–899. https://doi.org/10.1007/bf01746251
Goldenberg DM, Bhan RD, Pavia RA (1971) In vivo human-hamster somatic cell fusion indicated by glucose 6-phosphate dehydrogenase and lactate dehydrogenase profiles. Cancer Res 31(8):1148–1152
Goldenberg DM, Pavia RA, Tsao MC (1974) In vivo hybridisation of human tumour and normal hamster cells. Nature 250(5468):649–651. https://doi.org/10.1038/250649a0
Goldenberg DM, Rooney RJ, Loo M, Liu D, Chang CH (2014) In-vivo fusion of human cancer and hamster stromal cells permanently transduces and transcribes human DNA. PLoS One 9(9):e107927. https://doi.org/10.1371/journal.pone.0107927
Gupta GP, Massagué J (2006) Cancer metastasis: building a framework. Cell 127(4):679–695. https://doi.org/10.1016/j.cell.2006.11.001
Hanahan D (2022) Hallmarks of cancer: new dimensions. Cancer Discov 12(1):31–46. https://doi.org/10.1158/2159-8290.Cd-21-1059
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70. https://doi.org/10.1016/s0092-8674(00)81683-9
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674. https://doi.org/10.1016/j.cell.2011.02.013
Hass R, von der Ohe J, Dittmar T (2021) Hybrid formation and fusion of cancer cells in vitro and in vivo. Cancers (Basel) 13(17). https://doi.org/10.3390/cancers13174496
Jiang E, Yan T, Xu Z, Shang Z (2019) Tumor microenvironment and cell fusion. Biomed Res Int 2019:5013592. https://doi.org/10.1155/2019/5013592
Johansson CB, Youssef S, Koleckar K, Holbrook C, Doyonnas R, Corbel SY, Steinman L, Rossi FM, Blau HM (2008) Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic inflammation. Nat Cell Biol 10(5):575–583. https://doi.org/10.1038/ncb1720
Kerbel RS, Lagarde AE, Dennis JW, Donaghue TP (1983) Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol Cell Biol 3(4):523–538. https://doi.org/10.1128/mcb.3.4.523-538.1983
LaBerge GS, Duvall E, Grasmick Z, Haedicke K, Pawelek J (2017) A melanoma lymph node metastasis with a donor-patient hybrid genome following bone marrow transplantation: a second case of leucocyte-tumor cell hybridization in cancer metastasis. PLoS One 12(2):e0168581. https://doi.org/10.1371/journal.pone.0168581
LaBerge GS, Duvall E, Haedicke K, Pawelek J (2019) Leukocyte- cancer cell fusion-genesis of a deadly journey. Cells 8(2). https://doi.org/10.3390/cells8020170
LaBerge G, Duvall E, Grasmick Z, Haedicke K, Galan A, Pawelek J (2021) A melanoma patient with macrophage-cancer cell hybrids in the primary tumor, a lymph node metastasis and a brain metastasis. Cancer Genet 256-257:162–164. https://doi.org/10.1016/j.cancergen.2021.05.009
Larsson LI (2010) Cell fusions: regulation and control. Springer, Dordrecht
Lazova R, LaBerge GS, Duvall E, Spoelstra N, Klump V, Sznol M, Cooper D, Spritz RA, Chang JT, Pawelek JM (2013) A melanoma brain metastasis with a donor-patient hybrid genome following bone marrow transplantation: first evidence for fusion in human cancer. PLoS One 8(6):e66731. https://doi.org/10.1371/journal.pone.0066731
Leopold Wager CM, Wormley FL Jr (2014) Classical versus alternative macrophage activation: the Ying and the Yang in host defense against pulmonary fungal infections. Mucosal Immunol 7(5):1023–1035. https://doi.org/10.1038/mi.2014.65
Li W, Ma H, Zhang J, Zhu L, Wang C, Yang Y (2017) Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis. Sci Rep 7(1):13856. https://doi.org/10.1038/s41598-017-14364-2
Li H, Meng QH, Noh H, Somaiah N, Torres KE, Xia X, Batth IS, Joseph CP, Liu M, Wang R, Li S (2018) Cell-surface vimentin-positive macrophage-like circulating tumor cells as a novel biomarker of metastatic gastrointestinal stromal tumors. Oncoimmunology 7(5):e1420450. https://doi.org/10.1080/2162402x.2017.1420450
Liang K, Yaman S, Patel RK, Parappilly MS, Walker BS, Wong MH, Durmus NG (2022) Magnetic levitation and sorting of neoplastic circulating cell hybrids. bioRxiv. https://doi.org/10.1101/2022.11.03.515127
Lin EY, Pollard JW (2004) Macrophages: modulators of breast cancer progression. Novartis Found Symp 256:158–168. Discussion 168–172, 259–169
Lin D, Shen L, Luo M, Zhang K, Li J, Yang Q, Zhu F, Zhou D, Zheng S, Chen Y, Zhou J (2021) Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther 6(1). https://doi.org/10.1038/s41392-021-00817-8
Liu Q, Liao Q, Zhao Y (2016) Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance. Med Hypotheses 87:34–39. https://doi.org/10.1016/j.mehy.2015.12.007
Lu X, Kang Y (2009) Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc Natl Acad Sci U S A 106(23):9385–9390. https://doi.org/10.1073/pnas.0900108106
Malyshev I, Malyshev Y (2015) Current concept and update of the macrophage plasticity concept: intracellular mechanisms of reprogramming and M3 macrophage “switch” phenotype. Biomed Res Int 2015:341308. https://doi.org/10.1155/2015/341308
Manjunath Y, Mitchem JB, Suvilesh KN, Avella DM, Kimchi ET, Staveley-O’Carroll KF, Deroche CB, Pantel K, Li G, Kaifi JT (2020) Circulating giant tumor-macrophage fusion cells are independent prognosticators in patients with NSCLC. J Thorac Oncol 15(9):1460–1471. https://doi.org/10.1016/j.jtho.2020.04.034
Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14(7):399–416. https://doi.org/10.1038/nrclinonc.2016.217
Mekler LB (1971) [Hybridization of transformed cells with lymphocytes as 1 of the probable causes of the progression leading to the development of metastatic malignant cells]. Vestn Akad Med Nauk SSSR 26(8):80–89
Melzer C, Ohe JV, Hass R (2020) Altered tumor plasticity after different cancer cell fusions with MSC. Int J Mol Sci 21(21). https://doi.org/10.3390/ijms21218347
Melzer C, Ohe JV, Luo T, Hass R (2021) Spontaneous fusion of MSC with breast cancer cells can generate tumor dormancy. Int J Mol Sci 22(11). https://doi.org/10.3390/ijms22115930
Mohme M, Riethdorf S, Pantel K (2017) Circulating and disseminated tumour cells—mechanisms of immune surveillance and escape. Nat Rev Clin Oncol 14(3):155–167. https://doi.org/10.1038/nrclinonc.2016.144
Mohr M, Tosun S, Arnold WH, Edenhofer F, Zänker KS, Dittmar T (2015) Quantification of cell fusion events human breast cancer cells and breast epithelial cells using a Cre-LoxP-based double fluorescence reporter system. Cell Mol Life Sci 72(19):3769–3782. https://doi.org/10.1007/s00018-015-1910-6
Nel I, Jehn U, Gauler T, Hoffmann AC (2014) Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment. Transl Lung Cancer Res 3(2):100–106. https://doi.org/10.3978/j.issn.2218-6751.2014.03.05
Neubert NJ, Schmittnaegel M, Bordry N, Nassiri S, Wald N, Martignier C, Tillé L, Homicsko K, Damsky W, Maby-El Hajjami H, Klaman I, Danenberg E, Ioannidou K, Kandalaft L, Coukos G, Hoves S, Ries CH, Fuertes Marraco SA, Foukas PG, De Palma M, Speiser DE (2018) T cell-induced CSF1 promotes melanoma resistance to PD1 blockade. Sci Transl Med 10(436). https://doi.org/10.1126/scitranslmed.aan3311
Noy R, Pollard JW (2014) Tumor-associated macrophages: from mechanisms to therapy. Immunity 41(1):49–61. https://doi.org/10.1016/j.immuni.2014.06.010
Nygren JM, Liuba K, Breitbach M, Stott S, Thorén L, Roell W, Geisen C, Sasse P, Kirik D, Björklund A, Nerlov C, Fleischmann BK, Jovinge S, Jacobsen SE (2008) Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol 10(5):584–592. https://doi.org/10.1038/ncb1721
Parappilly MS, Chin Y, Whalen RM, Anderson AN, Robinson TS, Strgar L, Sutton TL, Conley P, Klocke C, Gibbs SL, Chang YH, Wu G, Wong MH, Skalet AH (2022) Circulating neoplastic-immune hybrid cells predict metastatic progression in uveal melanoma. Cancers (Basel) 14(19). https://doi.org/10.3390/cancers14194617
Park MD, Silvin A, Ginhoux F, Merad M (2022) Macrophages in health and disease. Cell 185(23):4259–4279. https://doi.org/10.1016/j.cell.2022.10.007
Parker KH, Beury DW, Ostrand-Rosenberg S (2015) Myeloid-derived suppressor cells: critical cells driving immune suppression in the tumor microenvironment. Adv Cancer Res 128:95–139. https://doi.org/10.1016/bs.acr.2015.04.002
Pawelek JM (2005) Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 6(12):988–993. https://doi.org/10.1016/s1470-2045(05)70466-6
Pawelek JM (2007) Viewing malignant melanoma cells as macrophage-tumor hybrids. Cell Adh Migr 1(1):2–6
Pawelek JM, Chakraborty AK (2008a) The cancer cell—leukocyte fusion theory of metastasis. Adv Cancer Res 101:397–444. https://doi.org/10.1016/s0065-230x(08)00410-7
Pawelek JM, Chakraborty AK (2008b) Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8(5):377–386. https://doi.org/10.1038/nrc2371
Peinado H, Marin F, Cubillo E, Stark HJ, Fusenig N, Nieto MA, Cano A (2004) Snail and E47 repressors of E-cadherin induce distinct invasive and angiogenic properties in vivo. J Cell Sci 117(Pt 13):2827–2839. https://doi.org/10.1242/jcs.01145
Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, Impey S, Wong MH (2011) Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res 71(4):1497–1505. https://doi.org/10.1158/0008-5472.Can-10-3223
Puluca N, Durmus NG, Lee S, Belbachir N, Galdos FX, Ogut MG, Gupta R, Hirano KI, Krane M, Lange R, Wu JC, Wu SM, Demirci U (2020) Levitating cells to sort the fit and the fat. Adv Biosyst 4(6):e1900300. https://doi.org/10.1002/adbi.201900300
Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39–51. https://doi.org/10.1016/j.cell.2010.03.014
Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH, Wong MH (2006) Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci U S A 103(16):6321–6325. https://doi.org/10.1073/pnas.0508593103
Senger DR, Perruzzi CA, Feder J, Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46(11):5629–5632
Silk AD, Gast CE, Davies PS, Fakhari FD, Vanderbeek GE, Mori M, Wong MH (2013) Fusion between hematopoietic and epithelial cells in adult human intestine. PLoS One 8(1):e55572. https://doi.org/10.1371/journal.pone.0055572
Skokos EA, Charokopos A, Khan K, Wanjala J, Kyriakides TR (2011) Lack of TNF-α-induced MMP-9 production and abnormal E-cadherin redistribution associated with compromised fusion in MCP-1-null macrophages. Am J Pathol 178(5):2311–2321. https://doi.org/10.1016/j.ajpath.2011.01.045
Stramer B, Mayor R (2017) Mechanisms and in vivo functions of contact inhibition of locomotion. Nat Rev Mol Cell Biol 18(1):43–55. https://doi.org/10.1038/nrm.2016.118
Sutton TL, Walker BS, Wong MH (2019) Circulating hybrid cells join the fray of circulating cellular biomarkers. Cell Mol Gastroenterol Hepatol 8(4):595–607. https://doi.org/10.1016/j.jcmgh.2019.07.002
Sutton TL, Patel RK, Anderson AN, Bowden SG, Whalen R, Giske NR, Wong MH (2022) Circulating cells with macrophage-like characteristics in cancer: the importance of circulating neoplastic-immune hybrid cells in cancer. Cancers (Basel) 14(16). https://doi.org/10.3390/cancers14163871
Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, Hollier BG, Ram PT, Lander ES, Rosen JM, Weinberg RA, Mani SA (2010) Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107(35):15449–15454. https://doi.org/10.1073/pnas.1004900107
Tocchio A, Durmus NG, Sridhar K, Mani V, Coskun B, El Assal R, Demirci U (2018) Magnetically guided self-assembly and coding of 3D living architectures. Adv Mater 30(4). https://doi.org/10.1002/adma.201705034
Toyoshima K, Hayashi A, Kashiwagi M, Hayashi N, Iwatsuki M, Ishimoto T, Baba Y, Baba H, Ohta Y (2015) Analysis of circulating tumor cells derived from advanced gastric cancer. Int J Cancer 137(4):991–998. https://doi.org/10.1002/ijc.29455
Vande Woude GF, Klein G (2009) Advances in cancer research. Elsevier, San Diego
Virchow R (1863) Cellular pathology as based upon physiological and pathological histology. Dover, New York
Walker BS, Sutton TL, Zarour L, Hunter JG, Wood SG, Tsikitis VL, Herzig DO, Lopez CD, Chen EY, Mayo SC, Wong MH (2021) Circulating hybrid cells: a novel liquid biomarker of treatment response in gastrointestinal cancers. Ann Surg Oncol 28(13):8567–8578. https://doi.org/10.1245/s10434-021-10379-2
Wang HF, Xiang W, Xue BZ, Wang YH, Yi DY, Jiang XB, Zhao HY, Fu P (2021) Cell fusion in cancer hallmarks: Current research status and future indications. Oncol Lett 22(1):530. https://doi.org/10.3892/ol.2021.12791
Wyckoff J, Wang W, Lin EY, Wang Y, Pixley F, Stanley ER, Graf T, Pollard JW, Segall J, Condeelis J (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64(19):7022–7029. https://doi.org/10.1158/0008-5472.Can-04-1449
Yilmaz Y, Lazova R, Qumsiyeh M, Cooper D, Pawelek J (2005) Donor Y chromosome in renal carcinoma cells of a female BMT recipient: visualization of putative BMT-tumor hybrids by FISH. Bone Marrow Transplant 35(10):1021–1024. https://doi.org/10.1038/sj.bmt.1704939
Zhang Y, Wang F, Ning N, Chen Q, Yang Z, Guo Y, Xu D, Zhang D, Zhan T, Cui W (2015) Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer. Int J Cancer 136(5):1228–1233. https://doi.org/10.1002/ijc.29070
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Patel, R.K. et al. (2024). The Hallmarks of Circulating Hybrid Cells. In: Kloc, M., Uosef, A. (eds) Syncytia: Origin, Structure, and Functions. Results and Problems in Cell Differentiation, vol 71. Springer, Cham. https://doi.org/10.1007/978-3-031-37936-9_21
Download citation
DOI: https://doi.org/10.1007/978-3-031-37936-9_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-37935-2
Online ISBN: 978-3-031-37936-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)